Arvinas (ARVN) Earnings Date & Reports

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ARVN is expected to report earnings to fall 55.88% to -39 cents per share on July 30

Q2'26

Est.

$-0.40

Q1'26

Beat

by $0.03

Q4'25

Missed

by $0.59

Q3'25

Beat

by $0.23

Q2'25

Beat

by $0.10

The last earnings report on May 12 showed earnings per share of -89 cents, beating the estimate of -93 cents. With 711.05K shares outstanding, the current market capitalization sits at 499.07M.

View a ticker or compare two or three

Compare

ARVN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ARVN